Intergroup Phase lll Randomized Study of Doxorubicin and Dacarbazine With or Without Ifosfamide and Mesna in Advanced Soft Tissue and Bone Sarcomas

Closed

Phase

Accrual

99%

Published

Abbreviated Title

Intergroup Phase lll Randomized Study of Doxorubicin and Dacarbazine With or Without Ifosfamide and Mesna in Advanced Soft Tissue and Bone Sarcomas

Activated

05/15/1987

Closed

07/01/1991

Research committees

Sarcoma

Publication Information Expand/Collapse

1998

A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma and rhabdomyosarcoma.

K Antman;J Crowley;SP Balcerzak;RA Kempf;RB Weiss;GH Clamon;LH Baker Cancer 82(7):1288-1295

1993

An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas.

KA Antman;J Crowley;SP Balcerzak;SE Rivkin;GR Weiss;A Elias;RB Natale;RM Cooper;B Barlogie;SL Trump;JH Doroshow;J Aisner;RP Pugh;RB Weiss;BA Cooper;GH Clamond;LH Baker JCO 11:1276-1285

1990

An intergroup (SWOG & CALGB) phase III randomized study of doxorubicin & dacarbazine with or without ifosfamide & mesna in advanced soft tissue & bone sarcomas.

K Antman;L Baker;S Balcerzak;J Crowley ASCO 9:311(#1203)